Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,210 total articles
Norwegian Cruise Line (NCLH) trades below $15 and beneath pre-2026 highs despite a clear path to margin recovery if management executes on pricing and operations. At roughly 9x reported earnings and an EV/EBITDA under 8x, the market is pricing in a deep downside scenario. This trade targets a mid-term recovery tied to booking momentum, yield stabil…
Hovnanian’s core homebuilding business shows reasonable operating cash flow, but outstanding preferred/warrant mechanics and elevated leverage create a material near-term downside risk. Technicals and short-interest data support a tactical short. Initiate a short at current levels with a mid-term horizon while monitoring clarity on preferred/warran…
Materion (MTRN) has been grinding higher off last year's low as demand for advanced electronic and aerospace materials recovers. Fundamentals and technicals suggest upside to near-term targets, and the risk/reward looks favorable if you accept a modestly elevated valuation. Trade plan provided for a long-term swing into $300 with a $245 stop.
<p>Montage Gold (MAUTF) looks set to transition from developer to producer as a first gold pour approaches. The market has already priced in a lot of the story - market cap sits near $5.58B - but there is room for a meaningful swing if commissioning goes smoothly and early production beats modest expectations. This is a tactical long with a defined…
Stryker's stock has been punished this month, pushing the shares to a 52-week low near $267. Oversold technicals, a healthy balance sheet, and $4.7B of trailing free cash flow suggest a mean-reversion trade. We'll lay out an entry, stop and target for a mid-term swing (45 trading days) while highlighting the key operational and macro risks that cou…
Corning (GLW) is the highest-conviction trade to play AI-driven demand for data-center interconnects. The company combines scale in fiber, favorable cash generation, and recent contract momentum while trading below peak multiples. We recommend a position entry at $166.00, stop at $153.00 and a target of $195.00 over a position-horizon trade (roughl…
Rollins (ROL) is a high-return recurring-revenue services business trading near its 52-week low after a margin miss and follow-on investor lawsuits. Fundamentals remain attractive - strong free cash flow, 37% ROE, moderate leverage and a growing dividend - while technicals show oversold conditions. This trade targets a mean-reversion to normalized …
Mastercard's acceleration in Value-Added Services (VAS), strong free cash flow ($16.7B), and a reasonable path to re-rating make MA a more attractive buy than Visa today. The stock is trading near $572.86 after a modest pullback; this trade targets $640 over a 180 trading-day horizon with a $540 stop.
Banco Santander (Brasil) trades at $6.02 with a $22.97B market cap, a 4.9% yield and improving technicals. The combination of above-average profitability, steady distributions and a supportive technical backdrop makes this a concrete long idea for investors willing to hold through Brazil macro noise for up to 180 trading days.
Barnes & Noble Education has struggled through accounting noise and revenue variability, but recent quarters show improving profitability and solid cash generation. At roughly $390M market cap and EV/EBITDA near 5.8, the stock looks inexpensive relative to its recovery trajectory. This trade targets a mid-term move as catalysts (earnings clarity, s…
Duluth Holdings has quietly converted a brand-first strategy into outsized free cash flow. With an enterprise value of roughly $203M, an EV/EBITDA of 5.4, and reported free cash flow of $57.54M, the stock looks materially undervalued versus its cash-generation profile. We recommend a long trade at $4.68, target $7.00, stop loss $3.50 and a long-ter…
Benchmark Electronics (BHE) is a profitable contract manufacturer with exposure to semiconductor capital equipment, lidar and aerospace/defense. Recent partnerships and record bookings position the company to capture early AI hardware manufacturing demand. With a market cap near $2.8B, low leverage and $126M in free cash flow, BHE looks attractive …
Exelixis pulled back after a recent FDA delay on a near-term filing, but the selloff overstates the hit. At $56.12 the company still trades at a reasonable multiple (P/E ~16) with strong free cash flow ($1.17B) and low leverage. This trade targets a recovery toward prior highs as clinical and commercial catalysts re-emerge.
Visa remains one of the most resilient long-term growth businesses in payments. The company is showing healthy profitability (ROE ~50.9%), strong free cash flow ($21.0B), and secular upside from Value-Added Services (VAS) and A2A monetization. We present a concrete trade plan to capture upside while protecting capital.
Jeronimo Martins faces a fork: operational leverage and private-label mix can drive a multi-quarter margin recovery, but heavy competition and currency/commodity pressures could keep returns muted. I outline a controlled long trade sized for tactical upside across 2026-2028 with defined entry, target and stop-loss levels.
Custom Truck One Source (CTOS) has pulled back from its 52-week high and is trading near technical and fundamental support. The business continues to show revenue growth, an improving operating profile, and an enterprise value that implies reasonable upside if margins and cash flow normalize. This trade idea lays out a concrete entry, stop and targ…
Qualcomm just landed an up-to-$60B AI chip deal with Amazon and is targeting $15B in data-center revenue by 2029. The stock trades at ~$182 with a 21x P/E and generates $10.4B in free cash flow — attractive if you believe Qualcomm can execute the pivot away from smartphones. This trade idea lays out an actionable long with entry, stop, targets, cat…
Broadcom is trading below recent highs while its AI semiconductor revenue and software portfolio are showing accelerating traction. The company screens expensive on headline multiples but delivers massive free cash flow, high ROE and near-term catalysts that could re-rate the stock. This trade plan targets a mid-term run toward $420, with a defined…
Rollins (ROL) is a dominant pest-control services platform with recurring revenue, high returns on capital and healthy cash flow. Recent weakness driven by softer digital leads and a disappointing quarter has pulled the stock from its 52-week high and left fundamentals that still look attractive. We present a trade plan to accumulate on weakness wi…
Mako reported record gold sales but lower profits. The market is pricing the story like both upside and execution risk are live. With a market cap of ~$883M, a P/E of 16.6 and the stock trading near $10, I lay out a mid-term swing trade: enter at $10.00, stop at $9.00, target $13.50 (mid term - 45 trading days).
Roivant trades like a biotech conglomerate: limited current cash flow, a heavy pipeline of asset-level catalysts and sizeable embedded value in its 'vants'. We like ROIV as a long trade into data and potential monetization events, with an entry at $41.00, stop at $33.00 and target at $60.00 over a long-term horizon (180 trading days). The trade bal…
Nano Labs (NA) is a sub-$60M microcap designing AI and high-performance computing chips while carrying meaningful BNB exposure that produced a large non-cash loss in H1 2026. Recent technical strength, a fresh hardware product and a North America MOU give a window for a mid-term swing trade. This idea sizes a tactical long with clear entry, stop an…
Nintendo is trading well below cyclical highs despite strong franchise momentum, blockbuster entertainment wins, and improving margin mix from software and services. This trade idea targets a mid-term re-rating as recurring software and entertainment revenue catches up with already-healthy console traction.
Kardigan is a clinical-stage precision cardiology company that recently secured financing to advance its lead programs and platform. The clinical roadmap plus platform licensing potential create multiple value pathways. We propose a long trade with disciplined risk management: enter at $3.25, stop at $1.95, target $7.50 over a 180-trading-day horiz…
Yancoal Australia reported a headline earnings miss that has put the stock under pressure. We believe the market is over-focused on reported profit while missing a clearer improvement in cash generation and balance-sheet flexibility. This trade idea buys the dip with a defined stop and a mid-term target tied to a normalization of coal prices and co…
